1107120

Acerta Pharma, LLC — FEI 3011684415

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Sponsor, Contract Research Organization